Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer - Rafael Rosell; Martyna Filipska; Imane Chaib; David Lligé; Fernando Laguia (Frontiers in Oncology, 2020)